Fungal infection and fever of unknown origin in neutropenic patients.
D000380:Agranulocytosis / Q000150:complications*; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D002408:Catheters, Indwelling / Q000009:adverse effects; D003453:Cryptococcosis / Q000188:drug therapy / Q000209:etiology; D003937:Diagnosis, Differential; D005335:Fever of Unknown Origin / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage; D009091:Mucormycosis / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D009503:Neutropenia / Q000150:complications*; D012306:Risk
D000935:Antifungal Agents; D008081:Liposomes; D000666:Amphotericin B